Candriam S.C.A. Forma Therapeutics Holdings, Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$7.12 - $20.24 $1.7 Million - $4.83 Million	-238,580 Reduced 81.51%	54,112 $1.08 Million
Q2 2021 Jul 20, 2021	BUY	$22.86 - $30.95 $3.88 Million - $5.25 Million	169,688 Added 137.95%	292,692 $7.29 Million
Q4 2020 Jan 22, 2021	SELL	$34.9 - $51.08 $4.17 Million - $6.11 Million	-119,578 Reduced 49.29%	123,004 $4.29 Million
Q3 2020 Oct 19, 2020	BUY	$32.95 - $50.25 $7.99 Million - $12.2 Million	242,582 New	242,582 $12.1 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.